View in EDS HTML Full Text PDF Full Text

Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.

Saved in:
Bibliographic Details
Title: Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.
Authors: Kamal MA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Kosloski MP; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Lai CH; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Partridge MA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Rajadhyaksha M; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Kanamaluru V; Sanofi, Bridgewater, NJ, United States., Bansal A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Shabbir A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Shumel B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Ardeleanu M; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Richards SM; Sanofi, Bridgewater, NJ, United States., Yan H; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Xu CR; Sanofi, Bridgewater, NJ, United States., Rodríguez-Marco A; Sanofi, Madrid, Spain., Xiao J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Khokhar FA; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Gherardi G; Sanofi, Reading, United Kingdom., Babilonia E; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Maloney J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Mortensen E; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Akinlade B; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Braunstein N; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Stahl N; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Torri A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., Davis JD; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States., DiCioccio AT; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Nov 11; Vol. 15, pp. 1466372. Date of Electronic Publication: 2024 Nov 11 (Print Publication: 2024).
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39588375
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kamal+MA%22">Kamal MA</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Kosloski+MP%22">Kosloski MP</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Lai+CH%22">Lai CH</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Partridge+MA%22">Partridge MA</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Rajadhyaksha+M%22">Rajadhyaksha M</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Kanamaluru+V%22">Kanamaluru V</searchLink>; Sanofi, Bridgewater, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Bansal+A%22">Bansal A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Shabbir+A%22">Shabbir A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Shumel+B%22">Shumel B</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Ardeleanu+M%22">Ardeleanu M</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Richards+SM%22">Richards SM</searchLink>; Sanofi, Bridgewater, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Yan+H%22">Yan H</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Xu+CR%22">Xu CR</searchLink>; Sanofi, Bridgewater, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Marco+A%22">Rodríguez-Marco A</searchLink>; Sanofi, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Xiao+J%22">Xiao J</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Khokhar+FA%22">Khokhar FA</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Gherardi+G%22">Gherardi G</searchLink>; Sanofi, Reading, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Babilonia+E%22">Babilonia E</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Maloney+J%22">Maloney J</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Mortensen+E%22">Mortensen E</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Akinlade+B%22">Akinlade B</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Braunstein+N%22">Braunstein N</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Stahl+N%22">Stahl N</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Torri+A%22">Torri A</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Davis+JD%22">Davis JD</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22DiCioccio+AT%22">DiCioccio AT</searchLink>; Regeneron Pharmaceuticals Inc., Tarrytown, NY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Nov 11; Vol. 15, pp. 1466372. <i>Date of Electronic Publication: </i>2024 Nov 11 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39588375
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1466372
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1466372
    Titles:
      – TitleFull: Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kamal MA
      – PersonEntity:
          Name:
            NameFull: Kosloski MP
      – PersonEntity:
          Name:
            NameFull: Lai CH
      – PersonEntity:
          Name:
            NameFull: Partridge MA
      – PersonEntity:
          Name:
            NameFull: Rajadhyaksha M
      – PersonEntity:
          Name:
            NameFull: Kanamaluru V
      – PersonEntity:
          Name:
            NameFull: Bansal A
      – PersonEntity:
          Name:
            NameFull: Shabbir A
      – PersonEntity:
          Name:
            NameFull: Shumel B
      – PersonEntity:
          Name:
            NameFull: Ardeleanu M
      – PersonEntity:
          Name:
            NameFull: Richards SM
      – PersonEntity:
          Name:
            NameFull: Yan H
      – PersonEntity:
          Name:
            NameFull: Xu CR
      – PersonEntity:
          Name:
            NameFull: Rodríguez-Marco A
      – PersonEntity:
          Name:
            NameFull: Xiao J
      – PersonEntity:
          Name:
            NameFull: Khokhar FA
      – PersonEntity:
          Name:
            NameFull: Gherardi G
      – PersonEntity:
          Name:
            NameFull: Babilonia E
      – PersonEntity:
          Name:
            NameFull: Maloney J
      – PersonEntity:
          Name:
            NameFull: Mortensen E
      – PersonEntity:
          Name:
            NameFull: Akinlade B
      – PersonEntity:
          Name:
            NameFull: Braunstein N
      – PersonEntity:
          Name:
            NameFull: Stahl N
      – PersonEntity:
          Name:
            NameFull: Torri A
      – PersonEntity:
          Name:
            NameFull: Davis JD
      – PersonEntity:
          Name:
            NameFull: DiCioccio AT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 11
              Text: 2024 Nov 11
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1